MedTrace Logo

Anxiety Among Children: Adaptation and Effectiveness of the Program Super Skills for Life in School Settings

NCT07162402 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2025-09-09

No results posted yet for this study

Summary

Super Skills for Life (SSL) is a transdiagnostic prevention program designed for children with anxiety and depressive symptoms based on cognitive-behavioral therapy. This study is a Cluster Randomization Trial(cRCT) to determine the of the effectiveness of the SSL program to reduce anxiety and depressive symptoms along with improving self-esteem, social skills and overall quality of life in a sample of 126, 5th grade children recruited from 6 schools from Pakistan.

Schools were the unit of randomization and were randomly assigned to one of two experimental conditions; intervention group (SSL) and waiting list control (WLC) group. Assessments were conducted before and after the 8 sessions of intervention and follow-up assessment after 6 months.

Conditions

  • Childhood Anxiety
  • Childhood Depression
  • Low Self-Esteem
  • Quality of Life (QOL)
  • Social Skills
  • Emotional Problems
  • Behavioral Problems

Interventions

OTHER

Super Skills for Life (SSL) Program

Its Cognitive Behaviour Therapy (CBT) Based 8 sessions Super Skills for Life (SSL) Program for childhood Anxiety Management.

OTHER

No Active Intervention

Routine Activities in Class

Sponsors & Collaborators

  • Fatima Jinnah Women University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Min Age
9 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-16
Primary Completion
2021-09-16
Completion
2021-09-16

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07162402 on ClinicalTrials.gov